Why the study?
Does calpeptin attenuate apoptosis and secondary inflammatory changes induced by extracellular inflammatory stimulation in muscle cells?
Does calpeptin attenuate apoptosis and secondary inflammatory changes induced by extracellular inflammatory stimulation in muscle cells?
Answers are grounded in this paper and cite their sources.
Calpain inhibition with calpeptin attenuates apoptosis and inflammatory changes in muscle cells, suggesting it as a potential therapeutic target for idiopathic inflammatory myopathies.
In idiopathic inflammatory myopathies (IIMs), extracellular inflammatory stimulation is considered to induce secondary intracellular inflammatory changes including expression of major histocompatibility complex class-I (MHC-I) and to produce a self-sustaining loop of inflammation. We hypothesize that activation of calpain, a Ca(2+) -sensitive protease, bridges between these extracellular inflammatory stress and intracellular secondary inflammatory changes in muscle cells. In this study, we demonstrated that treatment of rat L6 myoblast cells with interferon-γ (IFN-γ) caused expression of MHC-I and inflammation-related transcription factors (phosphorylated-extracellular signal-regulated kinase 1/2 and nuclear factor-κB). We also demonstrated that treatment with tumor necrosis factor-α (TNF-α) induced apoptotic changes and activation of calpain and cyclooxygenase-2. Furthermore, we found that posttreatment with calpeptin attenuated the intracellular changes induced by IFN-γ or TNF-α. Our results indicate that calpain inhibition attenuates apoptosis and secondary inflammatory changes induced by extracellular inflammatory stimulation in the muscle cells. These results suggest calpain as a potential therapeutic target for treatment of IIMs.
No takes yet. Share an insight, caveat, or question.
Nozaki et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: